Skip to main content
. 2022 Jan 10;44(3):352–363. doi: 10.1016/j.clinthera.2022.01.001

Figure 3.

Figure 3

Number of cycles, days per rolling review (RR) cycle, and timelines of the conditional marketing authorization (CMA) review for the vaccines that have been approved by the European Medicines Agency to date (November 2021).